Wu V Y, Cohen M P
Biochim Biophys Acta. 1984 Jan 24;797(1):76-82. doi: 10.1016/0304-4165(84)90384-2.
Platelet factor 4, a unique peptide released during platelet aggregation, can bind to natural sulfated glycosaminoglycans from human renal cortex. The glycosaminoglycan isolate contained components sensitive to hyaluronidase, chondroitinase ABC and nitrous acid. Binding was demonstrated by the change in electrophoretic mobility of platelet factor 4 applied in combination with glycosaminoglycan compared to either applied alone. This effect, which occurred at physiologic pH but not at acidic pH or with high ionic strength, was preserved in samples subjected to prior hyaluronidase and chondroitinase digestion. Further demonstration that platelet factor 4 can interact with heparan sulfate anionic sites in the glomerular microvascular matrix was obtained by incubating radiolabeled platelet factor 4 with isolated rat glomeruli, and with purified human and rat glomerular basement membrane, followed by displacement with heparin. Total binding and heparin-released binding were decreased in glomerular basement membrane prepared from diabetic patients and from rats with streptozotocin-diabetes compared to control samples. These findings implicate platelet factor 4 in the pathogenesis of the altered capillary integrity associated with diabetes, and provide novel evidence that heparan sulfate anionic sites in glomerular basement membrane are diminished in human and experimental diabetes.
血小板因子4是血小板聚集过程中释放的一种独特肽段,可与人肾皮质的天然硫酸化糖胺聚糖结合。该糖胺聚糖分离物含有对透明质酸酶、软骨素酶ABC和亚硝酸敏感的成分。与单独应用血小板因子4或糖胺聚糖相比,联合应用时血小板因子4电泳迁移率的变化证明了两者的结合。这种效应在生理pH值下出现,但在酸性pH值或高离子强度下不出现,在预先经透明质酸酶和软骨素酶消化的样品中仍然存在。通过将放射性标记的血小板因子4与分离的大鼠肾小球、纯化的人及大鼠肾小球基底膜一起孵育,然后用肝素置换,进一步证明了血小板因子4可与肾小球微血管基质中的硫酸乙酰肝素阴离子位点相互作用。与对照样品相比,糖尿病患者和链脲佐菌素诱导糖尿病大鼠制备的肾小球基底膜中的总结合和肝素释放结合均降低。这些发现表明血小板因子4参与了与糖尿病相关的毛细血管完整性改变的发病机制,并提供了新的证据,证明在人类和实验性糖尿病中,肾小球基底膜中的硫酸乙酰肝素阴离子位点减少。